Artificial Intelligence (AI) in Pharmaceutical - Global Top Players Market Share and Ranking 2024- YH Research

Home > Reports >Medical Care > Artificial Intelligence (AI) in Pharmaceutical - Global Top Players Market Share and Ranking 2024

Artificial Intelligence (AI) in Pharmaceutical - Global Top Players Market Share and Ranking 2024

Publication Date: 2024-01-24
Report Id: 1373016
Industry: Medical Care
Report Page: 142
Chart: 192

PDF Download

Publication Date: 2024-01-24
Report Id: 1373016
Industry: Medical Care
Report Page: 142
Chart: 192

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Artificial Intelligence (AI) in Pharmaceutical Definition
1.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast
1.3 China Artificial Intelligence (AI) in Pharmaceutical Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Artificial Intelligence (AI) in Pharmaceutical Market Size: China VS Global Growth Rate, 2019-2030
1.6 Artificial Intelligence (AI) in Pharmaceutical Market Dynamics
1.6.1 Artificial Intelligence (AI) in Pharmaceutical Market Drivers
1.6.2 Artificial Intelligence (AI) in Pharmaceutical Market Restraints
1.6.3 Artificial Intelligence (AI) in Pharmaceutical Industry Trends
1.6.4 Artificial Intelligence (AI) in Pharmaceutical Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Artificial Intelligence (AI) in Pharmaceutical, Global Market Share by Company, 2019-2024
2.2 Global Artificial Intelligence (AI) in Pharmaceutical Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Artificial Intelligence (AI) in Pharmaceutical Concentration Ratio
2.4 Global Artificial Intelligence (AI) in Pharmaceutical Mergers & Acquisitions, Expansion Plans
2.5 Global Artificial Intelligence (AI) in Pharmaceutical Major Companies Product Type
2.6 Head Office and Artificial Intelligence (AI) in Pharmaceutical Production Site of Key Manufacturer

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Artificial Intelligence (AI) in Pharmaceutical, China Market Share by Company, 2019-2024
3.2 China Artificial Intelligence (AI) in Pharmaceutical Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Artificial Intelligence (AI) in Pharmaceutical Industry Chain
4.2 Artificial Intelligence (AI) in Pharmaceutical Upstream Analysis
4.2.1 Artificial Intelligence (AI) in Pharmaceutical Core Raw Materials
4.2.2 Main Manufacturers of Artificial Intelligence (AI) in Pharmaceutical Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Artificial Intelligence (AI) in Pharmaceutical Production Mode
4.6 Artificial Intelligence (AI) in Pharmaceutical Procurement Model
4.7 Artificial Intelligence (AI) in Pharmaceutical Industry Sales Model and Sales Channels
4.7.1 Artificial Intelligence (AI) in Pharmaceutical Sales Model
4.7.2 Artificial Intelligence (AI) in Pharmaceutical Typical Distributors

5 Sights by Type
5.1 Artificial Intelligence (AI) in Pharmaceutical Classification
5.1.1 Hardware
5.1.2 Software
5.2 By Type, Global Artificial Intelligence (AI) in Pharmaceutical Consumption Value & CAGR, 2019 VS 2023 VS 2030
5.3 By Type, Global Artificial Intelligence (AI) in Pharmaceutical Consumption Value, 2019-2030

6 Sights by Application
6.1 Artificial Intelligence (AI) in Pharmaceutical Segment by Application
6.1.1 Pharmaceutical Company
6.1.2 Institute of Biology
6.1.3 Others
6.2 By Application, Global Artificial Intelligence (AI) in Pharmaceutical Consumption Value & CAGR, 2019 VS 2023 VS 2030
6.3 By Application, Global Artificial Intelligence (AI) in Pharmaceutical Consumption Value, 2019-2030

7 Sales Sights by Region
7.1 By Region, Global Artificial Intelligence (AI) in Pharmaceutical Consumption Value, 2019 VS 2023 VS 2030
7.2 By Region, Global Artificial Intelligence (AI) in Pharmaceutical Consumption Value, 2019-2030
7.3 North America
7.3.1 North America Artificial Intelligence (AI) in Pharmaceutical & Forecasts, 2019-2030
7.3.2 By Country, North America Artificial Intelligence (AI) in Pharmaceutical Market Size Market Share
7.4 Europe
7.4.1 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Artificial Intelligence (AI) in Pharmaceutical Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size Market Share
7.6 South America
7.6.1 South America Artificial Intelligence (AI) in Pharmaceutical Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Artificial Intelligence (AI) in Pharmaceutical Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Artificial Intelligence (AI) in Pharmaceutical Market Size & CAGR, 2019 VS 2023 VS 2030
8.2 By Country, Global Artificial Intelligence (AI) in Pharmaceutical Consumption Value, 2019-2030
8.3 U.S.
8.3.1 U.S. Artificial Intelligence (AI) in Pharmaceutical Market Size, 2019-2030
8.3.2 By Type, U.S. Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.3.3 By Application, U.S. Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.4 Europe
8.4.1 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size, 2019-2030
8.4.2 By Type, Europe Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.4.3 By Application, Europe Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.5 China
8.5.1 China Artificial Intelligence (AI) in Pharmaceutical Market Size, 2019-2030
8.5.2 By Type, China Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.5.3 By Application, China Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.6 Japan
8.6.1 Japan Artificial Intelligence (AI) in Pharmaceutical Market Size, 2019-2030
8.6.2 By Type, Japan Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.6.3 By Application, Japan Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.7 South Korea
8.7.1 South Korea Artificial Intelligence (AI) in Pharmaceutical Market Size, 2019-2030
8.7.2 By Type, South Korea Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.7.3 By Application, South Korea Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Artificial Intelligence (AI) in Pharmaceutical Market Size, 2019-2030
8.8.2 By Type, Southeast Asia Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.8.3 By Application, Southeast Asia Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.9 India
8.9.1 India Artificial Intelligence (AI) in Pharmaceutical Market Size, 2019-2030
8.9.2 By Type, India Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.9.3 By Application, India Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.10 Middle East & Africa
8.10.1 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size, 2019-2030
8.10.2 By Type, Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030
8.10.3 By Application, Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Consumption Value Market Share, 2023 VS 2030

9 Company Profile
9.1 AstraZeneca LLC
9.1.1 AstraZeneca LLC Company Information, Head Office, Market Area and Industry Position
9.1.2 AstraZeneca LLC Company Profile and Main Business
9.1.3 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.1.4 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.1.5 AstraZeneca LLC Recent Developments
9.2 Atomwise Inc
9.2.1 Atomwise Inc Company Information, Head Office, Market Area and Industry Position
9.2.2 Atomwise Inc Company Profile and Main Business
9.2.3 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.2.4 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.2.5 Atomwise Inc Recent Developments
9.3 Bayer AG
9.3.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
9.3.2 Bayer AG Company Profile and Main Business
9.3.3 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.3.4 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.3.5 Bayer AG Recent Developments
9.4 Cloud Pharmaceuticals Inc
9.4.1 Cloud Pharmaceuticals Inc Company Information, Head Office, Market Area and Industry Position
9.4.2 Cloud Pharmaceuticals Inc Company Profile and Main Business
9.4.3 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.4.4 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.4.5 Cloud Pharmaceuticals Inc Recent Developments
9.5 GNS Healthcare
9.5.1 GNS Healthcare Company Information, Head Office, Market Area and Industry Position
9.5.2 GNS Healthcare Company Profile and Main Business
9.5.3 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.5.4 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.5.5 GNS Healthcare Recent Developments
9.6 IBM Watson
9.6.1 IBM Watson Company Information, Head Office, Market Area and Industry Position
9.6.2 IBM Watson Company Profile and Main Business
9.6.3 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.6.4 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.6.5 IBM Watson Recent Developments
9.7 Merck & Co.
9.7.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position
9.7.2 Merck & Co. Company Profile and Main Business
9.7.3 Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.7.4 Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.7.5 Merck & Co. Recent Developments
9.8 Microsoft Corporation
9.8.1 Microsoft Corporation Company Information, Head Office, Market Area and Industry Position
9.8.2 Microsoft Corporation Company Profile and Main Business
9.8.3 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.8.4 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.8.5 Microsoft Corporation Recent Developments
9.9 Novartis AG
9.9.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
9.9.2 Novartis AG Company Profile and Main Business
9.9.3 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.9.4 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.9.5 Novartis AG Recent Developments
9.10 NVIDIA Corporation
9.10.1 NVIDIA Corporation Company Information, Head Office, Market Area and Industry Position
9.10.2 NVIDIA Corporation Company Profile and Main Business
9.10.3 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.10.4 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.10.5 NVIDIA Corporation Recent Developments
9.11 Pfizer Inc.
9.11.1 Pfizer Inc. Company Information, Head Office, Market Area and Industry Position
9.11.2 Pfizer Inc. Company Profile and Main Business
9.11.3 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.11.4 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.11.5 Pfizer Inc. Recent Developments
9.12 Recursion Pharmaceuticals Inc.
9.12.1 Recursion Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position
9.12.2 Recursion Pharmaceuticals Inc. Company Profile and Main Business
9.12.3 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.12.4 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.12.5 Recursion Pharmaceuticals Inc. Recent Developments
9.13 XtalPi Inc
9.13.1 XtalPi Inc Company Information, Head Office, Market Area and Industry Position
9.13.2 XtalPi Inc Company Profile and Main Business
9.13.3 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Models, Specifications and Application
9.13.4 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Revenue and Gross Margin, 2019-2024
9.13.5 XtalPi Inc Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Artificial Intelligence (AI) in Pharmaceutical should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies and analyses global Artificial Intelligence (AI) in Pharmaceutical status and future trends, to help determine the Artificial Intelligence (AI) in Pharmaceutical market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence (AI) in Pharmaceutical, and provides market size (US$ million) and Year-over-Year growth, considering 2023 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Artificial Intelligence (AI) in Pharmaceutical market size, history data 2019-2024, and forecast data 2025-2030, (US$ million)
(2) Global Artificial Intelligence (AI) in Pharmaceutical by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(3) China Artificial Intelligence (AI) in Pharmaceutical by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(4) Global Artificial Intelligence (AI) in Pharmaceutical key consuming regions, consumption value and demand structure
(5) Artificial Intelligence (AI) in Pharmaceutical industry chains, upstream, midstream and downstream
Market segment by players, this report covers
AstraZeneca LLC
Atomwise Inc
Bayer AG
Cloud Pharmaceuticals Inc
GNS Healthcare
IBM Watson
Merck & Co.
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer Inc.
Recursion Pharmaceuticals Inc.
XtalPi Inc

Market segment by Type, covers
Hardware
Software

Market segment by Application, can be divided into
Pharmaceutical Company
Institute of Biology
Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa

Report Includes:
Chapter 1: to describe Artificial Intelligence (AI) in Pharmaceutical product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Artificial Intelligence (AI) in Pharmaceutical market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 3: China Artificial Intelligence (AI) in Pharmaceutical market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 4: Artificial Intelligence (AI) in Pharmaceutical industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2019-2030
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2019-2030
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions